Italian skin disease registry aims to map treatment journeys for 20,000 patients
NCT ID NCT07336641
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will collect existing medical records from about 20,000 people aged 12 and older in Italy who have one of five inflammatory skin conditions: psoriasis, atopic dermatitis, vitiligo, alopecia areata, or hidradenitis suppurativa. Researchers want to describe who gets these diseases, what treatments they receive, and how their condition changes over time. No new treatments are being tested; the goal is simply to learn from real-world patient data.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALOPECIA AREATA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
IRCCS Istituto Clinico Humanitas - Dermatology Unit
Rozzano, Lombardy, 20089, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new injection calm severe eczema when creams fall short?
- Can a new pill help teens regrow hair lost to alopecia?
- Can a new biologic calm severe eczema?
- Can allergy and glaucoma drugs regrow hair when delivered by microneedling?
- Can a daily probiotic soothe colicky babies and calm eczema?
- Can a new injection match an existing eczema treatment?